To explore the impact of anaesthesia techniques on cancer outcomes and tumour progression, emphasizing their significance.
Key Findings:
Propofol shows direct antitumour effects by inhibiting proliferation and inducing apoptosis, with potential clinical implications.
Propofol enhances chemosensitivity and preserves immunological function compared to sevoflurane, suggesting a preference in certain cancer treatments.
Sevoflurane may have a positive effect in combination with immune checkpoint inhibitors, indicating a potential strategy for treatment.
Retrospective studies suggest a potential survival benefit for TIVA, but results are inconsistent across cancer types, highlighting the need for further investigation.
Prospective studies are limited, with some showing no significant differences in survival outcomes, underscoring the necessity for more comprehensive research.
Interpretation:
The choice of anaesthetic technique may influence cancer outcomes, but more robust clinical evidence is urgently needed to establish definitive conclusions.
Limitations:
Many studies are retrospective with potential confounding factors, such as patient selection and treatment variations.
Limited prospective studies with inconclusive results, necessitating further investigation.
Variability in cancer types and treatment protocols complicates comparisons, highlighting the need for standardized research methodologies.
Conclusion:
While anaesthesia may impact tumour progression and patient outcomes, further research is necessary to clarify these effects and guide clinical practice, emphasizing the importance of anaesthetic choices.
Systematic review found robotic-assisted total hip arthroplasty improved implant positioning precision without demonstrating better patient-reported outcomes or lower complication rates than conventional surgery.
